Literature DB >> 31499544

Clozapine Disrupts Endothelial Nitric Oxide Signaling and Antioxidant System for its Cardiovascular Complications.

Gayathri M Nair1, Dona Sheba Skaria1, Teenu James1, S K Kanthlal1.   

Abstract

OBJECTIVE: Many drugs in current practice require additional safety labels in order to prevent potential risks to the major organ system. Psychotropic agent clozapine has been reported to produce myocarditis and other cardiac complications on repeated use. Our study aimed to establish the role of clozapine in vascular damage associated with nitric oxide metabolism.
METHOD: Isolated aortic strips incubated with clozapine at different dose levels were estimated for nitrite release and antioxidant systems such as glutathione and catalase. Vascular integrity assessment was performed by recording the acetylcholine induced relaxation of phenyephrine pre-contracted aorta. RESULT: From our study, it was found that clozapine depletes the nitric oxide level in the endothelium and enhance the oxidative stress. The aorta fails to relax completely after the addition of acetylcholine indicates the deranged eNOS signaling in the endothelium.
CONCLUSION: From the experimental findings, it was concluded that clozapine could depress the eNOS regulation and thereby perhaps initiates cardiovascular complications through subsequent vascular events. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31499544     DOI: 10.1055/a-0991-7684

Source DB:  PubMed          Journal:  Drug Res (Stuttg)        ISSN: 2194-9379


  2 in total

Review 1.  Heart and brain interactions : Pathophysiology and management of cardio-psycho-neurological disorders.

Authors:  Renate B Schnabel; Gert Hasenfuß; Sylvia Buchmann; Kai G Kahl; Stefanie Aeschbacher; Stefan Osswald; Christiane E Angermann
Journal:  Herz       Date:  2021-02-05       Impact factor: 1.443

2.  Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction.

Authors:  K Fehsel; K Schwanke; B A Kappel; E Fahimi; E Meisenzahl-Lechner; C Esser; K Hemmrich; T Haarmann-Stemmann; G Kojda; C Lange-Asschenfeldt
Journal:  J Psychopharmacol       Date:  2022-01-03       Impact factor: 4.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.